NCT00331227View on ClinicalTrials.gov

Flavonoid Supplementation and Endothelial Function

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

December 31, 2006

Conditions
Healthy
Interventions
DRUG

Isotonix OPC-3 (flavonoid supplement)

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT00331227 - Flavonoid Supplementation and Endothelial Function | Biotech Hunter | Biotech Hunter